Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$11.29
+13.93%
Mkt Cap $279.68M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (14 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+121.5%
Consensus $25.00 vs current $11.29